NIH Charters Cancer Advisory Panel on Alternative Medicine
BETHESDA, Md-The National Institutes of Health (NIH) has chartered its Cancer Advisory Panel for Complementary and Alternative Medicine, limiting the group’s lifetime to 2 years unless it is formally renewed.
BETHESDA, MdThe National Institutes of Health (NIH) has chartered its Cancer Advisory Panel for Complementary and Alternative Medicine, limiting the groups lifetime to 2 years unless it is formally renewed.
The panel was initially organized last November to advise the directors of the NIH, the National Cancer Institute, and the National Center for Complementary and Alternative Medicine. The 13-member panel assesses summaries of evidence and makes recommendations about future directions in research. It is chaired by Ernst Wynder, MD, of the American Health Foundation.
Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care
Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.
